PedAM
Pediatric Disease Annotations & Medicines
| Disease | colorectal cancer |
| Phenotype | C0021390|inflammatory bowel disease |
| Sentences | 49 |
| PubMedID- 23709348 | The risk of developing colorectal cancer (crc) increases in patients with inflammatory bowel disease. |
| PubMedID- 24621115 | colorectal cancer in inflammatory bowel disease: a shift in risk. |
| PubMedID- 22522090 | Background & aims: the risk for colorectal cancer (crc) in patients with inflammatory bowel disease (ibd) could have changed over time, with changes in treatment options. |
| PubMedID- 25041864 | A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 22228163 | Patients: colorectal cancer cases associated with inflammatory bowel disease diagnosed between 1990 and 2006 were selected in a nationwide pathology archive. |
| PubMedID- 26518415 | Survival of colorectal cancer in patients with or without inflammatory bowel disease: a meta-analysis. |
| PubMedID- 22122774 | The risk of developing colorectal cancer is increased in patients with inflammatory bowel disease (ibd). |
| PubMedID- 23264896 | An exaggerated inflammatory response has been reported to increase the risk of colorectal cancer in patients with inflammatory bowel disease (ibd), ulcerative colitis (uc) or crohn’s disease. |
| PubMedID- 23407916 | Management of colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 23169309 | Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development. |
| PubMedID- 25840920 | Molecular alterations of colorectal cancer with inflammatory bowel disease. |
| PubMedID- 25531497 | colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. |
| PubMedID- 22876036 | colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk. |
| PubMedID- 21386829 | A classic paradigm is the enhanced risk of colorectal cancer (crc) in patients with inflammatory bowel disease (ibd). |
| PubMedID- 24076060 | Background & aims: although restorative proctocolectomy with ileal pouch-anal anastomosis (ipaa) substantially reduces the risk of colorectal cancer in patients with inflammatory bowel disease (ibd), subsequent pouch neoplasia can develop. |
| PubMedID- 21085072 | Surveillance for colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 22919240 | colorectal cancer in patients with inflammatory bowel disease: can we predict risk. |
| PubMedID- 20334955 | Conclusions: whereas htert immunostaining provides equivocal results, the observation that patients at high risk for colorectal cancer because of long-standing inflammatory bowel disease overexpress htert mrna in non-affected colorectal mucosa suggests its potential usefulness as a biomarker of the risk of malignant transformation. |
| PubMedID- 25337558 | The risk of developing colorectal cancer is increased in patients with inflammatory bowel disease (ibd). |
| PubMedID- 24280874 | Background: colitis-associated colorectal cancer affects individuals with inflammatory bowel disease (ibd) more often and earlier than cancer in the general population. |
| PubMedID- 23619008 | Background and aims: data on the relative risk of colorectal cancer in inflammatory bowel diseases (ibd) are inconsistent. |
| PubMedID- 22369306 | Chronic inflammation plays a pivotal role in the development of colorectal cancer (crc) in patients with inflammatory bowel disease (ibd). |
| PubMedID- 19863607 | Aim: colorectal cancer is associated with inflammatory bowel disease. |
| PubMedID- 24788218 | Background: active colitis impairs neoplasia detection during colonoscopic surveillance for colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 20670073 | In the discussion, characteristics and major risk factors for colorectal cancer in patients with inflammatory bowel disease will be largely reviewed, and current studies will be analyzed in connection with the appearance of neoplasms in patients being treated with biologics. |
| PubMedID- 24407106 | Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases. |
| PubMedID- 24463282 | The risk of developing colorectal cancer is increased in patients with inflammatory bowel disease. |
| PubMedID- 23664897 | colorectal cancer in inflammatory bowel disease: results of the 3rd ecco pathogenesis scientific workshop (i). |
| PubMedID- 25110418 | colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. |
| PubMedID- 22878887 | colorectal cancer in inflammatory bowel diseases: ct features with pathological correlation. |
| PubMedID- 25515241 | The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from korea. |
| PubMedID- 22164923 | This position paper of the section of gastrointestinal oncology of the israeli gastroenterological association recommends specific guidelines for colorectal cancer surveillance in patients with inflammatory bowel disease. |
| PubMedID- 25157526 | The risk for developing dysplasia and colorectal cancer in patients with longstanding inflammatory bowel disease (ibd) involving the colon is well documented. |
| PubMedID- 23086115 | Background: differentiating surveillance from non-surveillance colonoscopy for colorectal cancer in patients with inflammatory bowel disease (ibd) using electronic medical records (emr) is important for practice improvement and research purposes, but diagnosis code algorithms are lacking. |
| PubMedID- 22585652 | [colorectal cancer in inflammatory bowel diseases]. |
| PubMedID- 26079724 | Background: colonic strictures and epithelial dysplasia are both known risk factors for the occurrence of colorectal cancer in inflammatory bowel disease (ibd) patients. |
| PubMedID- 24282346 | Has the risk of colorectal cancer in inflammatory bowel disease decreased. |
| PubMedID- 20184639 | colorectal cancer complicating inflammatory bowel disease: a comparative study of crohn's disease vs ulcerative colitis in 34 patients. |
| PubMedID- 25278673 | colorectal cancers in inflammatory bowel disease patients are considered typical examples of inflammation-related cancers. |
| PubMedID- 25557336 | Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease. |
| PubMedID- 22467511 | colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008). |
| PubMedID- 23401648 | Similarly, aminosalicylates such as sulfasalazine, mesalazine, and others have been shown to reduce the risk for colitis-associated colorectal cancer (cac) in patients with inflammatory bowel disease [5]. |
| PubMedID- 21820431 | In particular, decreased e-cadherin-mediated adhesion during inflammatory bowel disease and loss of ephb/ephrin-b-mediated compartmentalization in colorectal cancer have recently emerged as key players of these prevalent pathologies. |
| PubMedID- 22398065 | Background: the increased risk of colorectal cancer (crc) in patients with inflammatory bowel disease (ibd) is well established. |
| PubMedID- 22523611 | colorectal cancer surveillance in patients with inflammatory bowel disease: what is new. |
| PubMedID- 25531498 | This review summarizes the advances and current standards of colorectal cancer prevention in patients with inflammatory bowel disease, fap and lynch syndrome. |
| PubMedID- 24760232 | The possibility of field cancerization in the colon was first suggested by the increased occurrence of flat dysplasia and colorectal cancer in individuals with inflammatory bowel disease. |
| PubMedID- 25230162 | colorectal cancer surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis: an economic evaluation. |
| PubMedID- 24117071 | inflammatory bowel disease increases the risks of human colorectal cancer. |
Page: 1